Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UR-63325 in Seasonal Allergic Rhinitis
NCT01260753Phase 2Completed
- Sponsor
- Palau Pharma
- Start
- Dec 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of seliforant in seasonal allergic rhinitis (SAR), sponsored by Palau Pharma. Started Dec 2010; status: completed.
02
Drugs
seliforant
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01260753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01260753.